ebv

gics offer a targeted method to neutralize the virus or mark infected cells for immune clearance. Early-phase clinical trials indicate promising safety and efficacy profiles, though widespread availability remains a future prospect. Comparative Analysis: EBV Vaccines Vaccination represents one of t